The team of Xiushi utilizes synthetic biology methods to design, discover, construct, and modify a series of important biological components and chassis cells suitable for peptide drug development, breaking through the technical bottlenecks of biosynthesizing short peptides, complex peptides, and modified peptides.
Combining advanced synthetic biology technology with a comprehensive peptide drug development platform, Xiushi Biotech reduces the preclinical research costs and shortens the cycle of peptide innovative drugs. Through the "design-build-test-analyze" iterative process, it accelerates the development projects towards clinical trials.